Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.

Chamcheu JC, Esnault S, Adhami VM, Noll AL, Banang-Mbeumi S, Roy T, Singh SS, Huang S, Kousoulas KG, Mukhtar H.

Cells. 2019 Sep 15;8(9). pii: E1089. doi: 10.3390/cells8091089.

2.

Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.

Chamcheu JC, Roy T, Uddin MB, Banang-Mbeumi S, Chamcheu RN, Walker AL, Liu YY, Huang S.

Cells. 2019 Jul 31;8(8). pii: E803. doi: 10.3390/cells8080803. Review.

3.

Engineering a titanium and polycaprolactone construct for a biocompatible interface between the body and artificial limb.

Smith CM, Roy TD, Bhalkikar A, Li B, Hickman JJ, Church KH.

Tissue Eng Part A. 2010 Feb;16(2):717-24. doi: 10.1089/ten.TEA.2009.0066.

PMID:
19769529
4.

Performance of degradable composite bone repair products made via three-dimensional fabrication techniques.

Roy TD, Simon JL, Ricci JL, Rekow ED, Thompson VP, Parsons JR.

J Biomed Mater Res A. 2003 Aug 1;66(2):283-91.

PMID:
12888998
5.

Engineered cellular response to scaffold architecture in a rabbit trephine defect.

Simon JL, Roy TD, Parsons JR, Rekow ED, Thompson VP, Kemnitzer J, Ricci JL.

J Biomed Mater Res A. 2003 Aug 1;66(2):275-82.

PMID:
12888997

Supplemental Content

Loading ...
Support Center